Physician profile
David S Lu
NPI 1073542668
$112,728.24
in general payments reported to CMS, 2019-2025
13 companies · $2,928 in 2025
The $2,928 reported for 2025 was more than what 80% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81K · 2020: $23K · 2021: $4,915 · 2022: $538 · 2023: $319 · 2024: $353 · 2025: $2,928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,442 · Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,441.93 |
| Food and Beverage | $1,158.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $107,276.93 | 2019-2021 | |
| Histosonics, INC. | $2,441.93 | 2025 | |
| Ethicon US, LLC | $1,298.67 | 2019-2025 | Neuwave, Certus 140 |
| Galvanize Therapeutics, INC | $465.44 | 2023-2025 | Aliya System |
| Boston Scientific Corporation | $397.36 | 2021-2024 | |
| Siemens Medical Solutions USA, INC. | $266.52 | 2019-2025 | |
| Angiodynamics, INC. | $211.48 | 2021 | |
| Philips North America LLC | $100.00 | 2022 | |
| Ethicon Endo-Surgery INC. | $97.79 | 2020 | |
| Ge Healthcare | $75.09 | 2024 | |
| Covidien LP | $65.05 | 2019 | |
| Medtronic, INC. | $31.98 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.